The mitral valve manages blood flow between left atrium and left ventricle; and prevents backward flow of the blood into left atrium. Mitral regurgitation is leakage of blood backward through the mitral valve each time the left ventricle contracts. This is a most common mitral valve disorder that causes abnormal blood flow. As a remedy for this problem, surgeons use mitral surgical vale repair procedures or transcatheter replacement methods.
Some of the key driving factors attributing to the growth of this market include increasing number of patients with mitral valve disorders. Approximately 7 million people in the U.S., suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffer from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation.
The number of new patients suffering with mitral regurgitation disease added each year is 250,000. Among this 4.1 million patients, only about 20% or 1.67 million are eligible for the treatment. This creates huge opportunity for the global transcatheter mitral valve replacement market.
In addition, increasing adoption of minimally invasive procedures over traditional surgical open heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss are further propelling the market. According to World Health Organization (WHO), it has been estimated that the number of people suffering from cardiovascular diseases will increase to 22.2 million by 2030.
The market for TMVR is expected to reach around USD 3.0 billion by 2022, growing at a CAGR of 15.9% during the forecast period of 2016e to 2022f. However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs associated with the LMVD implantation compared to other therapies available for CVD diseases.
Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness about minimally invasive surgical procedures among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.
The report delivers a strategic analysis of the global market for TMVRs and growth forecast for the period from 2016e - 2022f. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of indication. It also covers geographical analysis of the market with growth forecast for the period of 2016e - 2022f. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.
The study also provides information for recent merger and acquisition deals happened in the global TMVR market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global TMVR market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies
The company profile section include detailed analysis of some of the key players such as Edwards Lifesciences Corp., Abbott Laboratories, Medtronic, Micro Interventional Devices, Neovasc. Sinomed, etc.
1.1.1 Report description
1.1.2 Research methodology
1.1.3 List of abbreviations
1.1.4 Market segmentation
1.2 Executive summary
1.3 Qualitative analysis
1.3.1 Market overview
1.3.2 Value chain analysis
1.3.3 Porters five forces analysis
1.3.4 Key M&A trends and strategic partnerships
1.3.5 Competitive matrix of the key companies
1.4 Global TMVR market, by geography, 2014-2022f
1.4.1 North America
1.4.4 Rest of the World
1.5 Company profiles
1.5.1 Edwards Lifesciences Corp.
1.5.2 Medtronic plc
1.5.3 Abbott Laboratories
1.5.4 Micro Interventional Devices